Journal of Medicinal Chemistry· 2026Q1
Dual Peptide Modification via Isopeptide Bonding and Lipidation Boosts Antifungal Activity
- 0citations
- Q1SCImago
- 2026year
Short summary
A novel lipo-isopeptide (LIIP) modification of antimicrobial peptides (AMPs) enhances antifungal activity against Candida albicans and reduces resistance development.
AI-generated from the title and abstract; the full text is not read.
Key points
- Lipo-isopeptides (LIIPs) were created by modifying antimicrobial peptides (AMPs) with isopeptide bonds and lipophilic acids.
- LIIPs exhibited broad antimicrobial activity, especially against Candida albicans, and increased protease resistance.
- Modifications enhanced membrane affinity and altered peptide structure, leading to membrane disruption and depolarization.
- The C8-Amp1EP LIIP reduced fungal adhesion and biofilm formation, and showed lower resistance development potential than standard antifungals.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract The rapid rise in drug-resistant infectious diseases urgently demands new therapeutic strategies, particularly against fungi. Antimicrobial peptides (AMPs) are key effectors of innate immunity in all organisms, killing various microorganisms. Despite their potential, few AMPs effectively target pathogens without harming the host. Here, we incorporated isopeptide bonds and lipophilic acids into AMPs, forming lipo-isopeptides (LIIPs). LIIPs were active against diverse microorganisms, predominantly Candida albicans (C. albicans), and exhibited improved protease resistance. These modifications altered the secondary structure and oligomerization behavior, while enhancing membrane affinity. Consequently, by coating surfaces and cells, the non-toxic C8-Amp1EP reduces fungal adhesion and biofilm formation, and acts by disrupting and depolarizing the C. albicans membrane at both planktonic and biofilm stages. Importantly, under serial-passage conditions, C8-Amp1EP showed a lower propensity to induce resistance than conventional antifungal treatments. These findings identify LIIPs as promising, selective agents for combating infections, paving the way for future therapeutic development.
The authors' abstract, as published at the source. Journal of Medicinal Chemistry, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
MicrobiologyImmunology and Microbiology